spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  gadolinium 

 HSMN NewsFeed - 4 Mar 2026
First-in-Human Use of CereVasc(R) eShunt(R) System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes
Devices Neurosurgery
 HSMN NewsFeed - 16 Oct 2024
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY(TM) Software for Enhanced MRI
Devices Radiology FDA
 HSMN NewsFeed - 10 Mar 2021
Subtle Medical Launches SubtleMR(TM) 2.0 to Expand Improved MRI Capabilities
Devices Radiology FDA Product Launch
 HSMN NewsFeed - 23 Dec 2020
FDA Approves Bracco Diagnostics Inc.'s ProHance(R) (Gadoteridol) Injection, 279.3 mg/mL, for Pediatric Patients Younger than Two Years
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Dec 2018
Subtle Medical Receives FDA 510(k) Clearance and CE Mark Approval for SubtlePET(TM)
Devices Radiology FDA Regulatory
 HSMN NewsFeed - 30 Jan 2018
Bracco Diagnostics Inc. receives U.S. Food and Drug Administration (FDA) approval for use of MultiHance(R) (gadobenate dimeglumine) injection in magnetic resonance imaging of the central nervous system in pediatric patients younger than two years of age
Biopharmaceuticals Devices Diagnostics Radiology FDA
 HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 29 Mar 2017
FDA Approves Genentech’s OCREVUS(TM) (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Dec 2016
Positive Phase III Results of Genentech’s Investigational Medicine OCREVUS(TM) (Ocrelizumab) Published in New England Journal of Medicine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jun 2015
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif(R)) in Two Phase III Studies in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Jun 2014
FDA approves Bayer's Gadavist (gadobutrol) Injection as the first magnetic resonance contrast agent for evaluation of breast cancer in the United States
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 27 Nov 2013
CMC Contrast Granted Orphan Drug Designation by the FDA for its Liver Specific MRI Contrast Media CMC-001
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 4 Oct 2013
New TECFIDERA(R) (Dimethyl Fumarate) Data Show Sustained Efficacy and Long-Term Safety in a Broad Range of Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Oct 2013
Aubagio(R) Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Oct 2012
New Data from Phase 3 Studies Provide Additional Evidence Supporting Treatment Effect for Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Apr 2011
Biogen Idec Announces Positive Top-Line Results from the First Phase 3 Trial Investigating Oral BG-12 (DIMETHYL FUMARATE) in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Mar 2011
U.S. FDA Approves Bayer's Gadavist (Gadobutrol) Injection for MRI of the Central Nervous System
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 21 Jan 2011
Lantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR(R) and DEFINITY(R)
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 2 Dec 2010
New Toshiba Vantage Titan HSR 1.5T Produces Outstanding Image Quality for Advanced MR Applications
Devices Radiology
 HSMN NewsFeed - 22 Sep 2010
Biogen Idec Makes Statement About U.S. FDA Approval of Gilenya
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Aug 2010
Toshiba Installs 1,000th MR System Worldwide
Devices Radiology
 HSMN NewsFeed - 30 Aug 2010
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Jun 2010
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Jan 2010
Lantheus Medical Imaging, Inc. Launches ABLAVAR (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent
Biopharmaceuticals Radiology
 HSMN NewsFeed - 9 Feb 2009
MS Patients Treated with TYSABRI Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Dec 2008
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
Biopharmaceuticals Radiology
 HSMN NewsFeed - 22 Sep 2008
Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Sep 2008
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jul 2008
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 3 Jun 2008
NOVA(R) Renal: A Safe Alternative to Contrast Enhanced MRA/MRI
Devices Radiology
 HSMN NewsFeed - 15 Apr 2008
Biogen Idec and Elan Present New TYSABRI(R) Data at the 60th Annual Meeting of the American Academy of Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Apr 2008
Study Shows that High-Dose, High-Frequency Interferon Produces no Additional Benefit on Efficacy Compared to AVONEX(R) (interferon beta-1a) in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Mar 2008
Toshiba Installs Milestone 500th Vantage 1.5T MR System at Jefferson Regional Medical Center
Devices Radiology
 HSMN NewsFeed - 1 Feb 2008
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jan 2008
Toshiba Receives FDA Clearance for Vantage Titan MR System
Devices Radiology FDA
 HSMN NewsFeed - 21 Dec 2007
Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Nov 2007
Toshiba Introduces New Vantage Titan MR System at RSNA
Devices Radiology
 HSMN NewsFeed - 20 Nov 2007
Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 15 Nov 2007
Toshiba Announces Its Fourth Generation Contrast-Free Technique -- Time and Space Angiography (TSA)
Devices Radiology
 HSMN NewsFeed - 8 Nov 2007
Bayer HealthCare Pharmaceuticals, HealthTrust Purchasing Group Sign a Three-Year Renewal Agreement for Magnevist(R) Magnetic Resonance Contrast Media
Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 3 Oct 2007
Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
Diagnostics
 HSMN NewsFeed - 19 Sep 2007
Pharmacyclics Announces Addition of Robert W. Duggan to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2007
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Sep 2007
Pharmacyclics Announces Encouraging Phase 2 Data With Xcytrin(R) in Recurrent Non-Small Cell Lung Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Jul 2007
Accentia Biopharmaceuticals Files Pre-Investigational New Drug (IND) Application with FDA for Pivotal Phase 3 Clinical Trial of Revimmune for Refractory Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Jul 2007
Premier Extends Agreement With Bayer HealthCare Pharmaceuticals
Biopharmaceuticals Radiology Group Purchasing
 HSMN NewsFeed - 3 Jun 2007
Pharmacyclics Announces Positive Final Results of Phase 2 Trial of Xcytrin(R) Plus Radiosurgery for Brain Metastases With Occult Tumors Detected in 24% of Patients
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 17 May 2007
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 May 2007
Pharmacyclics Announces Appointment of Michael K. Inouye as Senior Vice President of Corporate and Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2007
Treatment with COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 May 2007
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Apr 2007
Pharmacyclics Announces FDA Filing of New Drug Application for Xcytrin(R) Injection to Treat Lung Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Apr 2007
350th Installed MAGNETOM Trio Demonstrates the Clinical Need for High-Field MRI
Devices Radiology
 HSMN NewsFeed - 4 Apr 2007
Toshiba MR Systems Allow for Safe MRA Exams
Devices Radiology
 HSMN NewsFeed - 4 Apr 2007
Pharmacyclics' Xcytrin New Drug Application for Treatment of Lung Cancer Brain Metastases to Be Filed Over Protest
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Mar 2007
MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Mar 2007
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Mar 2007
The Immune Response Corporation Injects First Patient in Trial of NeuroVax(TM) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Feb 2007
Post-Hoc Data Analyses Published in Annals of Neurology Found COPAXONE(R) Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Feb 2007
Pharmacyclics Receives Refuse to File Letter for Xcytrin
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2007
EPIX Pharmaceuticals Presents Data from Novel MRI Imaging Agent at the Society for Cardiovascular Magnetic Resonance Meeting
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 24 Jan 2007
Merck Serono Has Initiated the ONWARD Study to Evaluate Oral Cladribine as Add-on Treatment for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Jan 2007
Biogen Idec Initiates Phase III Clinical Program of Oral Compound BG-12 for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Dec 2006
Pharmacyclics Submits New Drug Application for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Nov 2006
Pharmacyclics Announces Presentation of Pooled Analysis of Xcytrin(R) for Lung Cancer Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Nov 2006
Pharmacyclics Announces Presentation of Preliminary Results From Phase 2 Clinical Trial of Xcytrin(R) With Radiosurgery for Brain Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Oct 2006
Hologic to Showcase the Latest in Women's Imaging & Skeletal Health Innovations at the Largest Medical Show in the World - RSNA'06
Devices Radiology
 HSMN NewsFeed - 6 Oct 2006
New Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Very Active Multiple Sclerosis Patients Benefited from COPAXONE(R) Treatment Following Short-Term Induction with Mitoxantrone
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 May 2006
Biogen Idec to Acquire Fumapharm AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2006
Oral Compound BG-12 Achieves Primary Endpoint in Phase II Study of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 May 2006
Pharmacyclics to Submit New Drug Application for Xcytrin(R) for Treatment of Lung Cancer Patients With Brain Metastases
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 47

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 47 additional stories matching:
gadolinium
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.